| Bid Price | 13.50p | High Price | 14.00p |
|---|
| Ask Price | 14.00p | Low Price | 13.50p |
|---|
| Open Price | 13.75p | Spread | 3.57% |
|---|
| Prev Close | 13.75p | Volume | 145,004 |
|---|
Ondine Biomedical Inc. Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jul 8, 2025 | 13.75 | 14.00 | 13.50 | 13.75 | 145,004 |
| Jul 7, 2025 | 14.25 | 14.30 | 13.65 | 13.75 | 283,512 |
| Jul 4, 2025 | 14.25 | 14.75 | 14.06 | 14.25 | 22,762 |
| Jul 3, 2025 | 14.25 | 14.35 | 13.50 | 14.25 | 119,373 |
| Jul 2, 2025 | 14.25 | 14.37 | 14.36 | 14.25 | 5,992 |
Ondine Biomedical Inc. Information
| Name | Ondine Biomedical Inc. | Index | FTSE AIM All Share |
|---|
| ISIN | CA68234M2058 | Epic | OBI |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 20,000 | Trading Status | Closed |
|---|
| Shares in Issue | 443.43 m | Prev Close | 13.75p |
|---|
| PE Ratio | | Market Cap | £60.97 m |
|---|
| Div Yield | 0 | Div per Share | NaN CAD |
|---|
| EPS | -0.04 CAD | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -3.059474 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.050126 | Quick Ratio | 1.729184 |
|---|
Ondine Biomedical Inc. Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 04/02/25 | BUY | Carolyn Cross | CEO | 149,225 @ £0.13 | £18,653.00 |
| 03/02/25 | BUY | Carolyn Cross | CEO | 100,000 @ £0.13 | £12,500.00 |
| 31/01/25 | BUY | Carolyn Cross | CEO | 200,775 @ £0.12 | £24,093.00 |
| 31/01/25 | BUY | Margaret Shaw | NED | 30,000 @ £0.12 | £3,600.00 |
| 22/11/24 | PLAC | Carolyn Cross | CEO | 18,710,100 @ £0.09 | £1,590,359.00 |
| 22/11/24 | PLAC | Margaret Shaw | NED | 197,186 @ £0.09 | £16,761.00 |
| 22/11/24 | PLAC | Junaid Bajwa | NED | 384,920 @ £0.09 | £32,718.00 |
| 22/11/24 | PLAC | Jean Duvall | NED | 419,912 @ £0.09 | £35,693.00 |
| 22/11/24 | PLAC | Michael Farrar | RES | 174,963 @ £0.09 | £14,872.00 |
| 11/11/24 | PLAC | Carolyn Cross | CEO | 1,305,188 @ £0.09 | £110,941.00 |
Ondine Biomedical Inc. News
